Skip to content

Orion Pharma brand
Contact us
- Our locations
  
  Australia
  
  Austria
  
  Belgium nl fr
  
  China
  
  Czech Republic
  
  Denmark
  
  Estonia
  
  Finland fi en
  
  France
  
  Germany
  
  Hungary
  
  India
  
  Ireland
  
  Italy
  
  Japan
  
  Kazakhstan ru kz
  
  Latvia
  
  Lithuania
  
  Malaysia
  
  Netherlands nl fr
  
  Norway
  
  Poland
  
  Singapore
  
  Slovenia
  
  Spain
  
  Sweden
  
  Switzerland
  
  Thailand
  
  UK
  
  Ukraine
Visit global site 

Building well-being means the world to us

Discover more

Interim report January-March 2026

Orion will publish Interim Report for January–March 2026 on Thursday, 23 April 2026 at approximately 12.00 noon EEST.

Read the report

Annual General Meeting 2026

The Annual General Meeting 2026 of Orion Corporation was held on 24 March 2026.

Stock exchange releases

All releases 

Press releases

All releases 

Translating world-class science into novel life-changing therapies

Orion’s pharmaceutical R&D focuses on oncology and pain.

Read more about our R&D 

Join us in building well-being!

Your work builds well-being, drives innovation, and impacts millions of lives around the world.

Read more about open vacancies at Orion and Fermion 

Partnering with Orion

Partner with us to create world-class innovative solutions with ambition at every step of the way.

Read more about partnering with us 

Building well-being for over a century already

Together, we build well-being by putting patients at the heart of everything we do – from groundbreaking therapies to trusted treatments.

Read more about our core therapy areas 